Paper37589458
Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis.
Steagall WK and 4 others. ERJ Open Res, 2023. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis. Papers, record 37589458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37589458
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZIAHL002541 | NIH |
Source NIH RePORTER
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11834679 | Airway hyperresponsiveness and calcium handling by smooth muscle: a "deeper look". | Chest | 2002 | https://conductscience.org/library/papers/11834679 | PubMed |
| 2 | 32108050 | Quantitative analysis of airway obstruction in lymphangioleiomyomatosis. | Eur Respir J | 2020 | https://conductscience.org/library/papers/32108050 | PubMed |
| 3 | 34461049 | Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. | Lancet Respir Med | 2021 | https://conductscience.org/library/papers/34461049 | PubMed |
| 4 | 26799509 | A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis. | Ann Am Thorac Soc | 2016 | https://conductscience.org/library/papers/26799509 | PubMed |
| 5 | 24053175 | Dissociation of FK506-binding protein 12.6 kD from ryanodine receptor in bronchial smooth muscle cells in airway hyperresponsiveness in asthma. | Am J Respir Cell Mol Biol | 2014 | https://conductscience.org/library/papers/24053175 | PubMed |
| 6 | 33882264 | Mast-Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis. | Am J Respir Crit Care Med | 2021 | https://conductscience.org/library/papers/33882264 | PubMed |
| 7 | 23305987 | Airway smooth muscle in the pathophysiology and treatment of asthma. | J Appl Physiol (1985) | 2013 | https://conductscience.org/library/papers/23305987 | PubMed |
| 8 | 31404502 | A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations. | Ann Am Thorac Soc | 2019 | https://conductscience.org/library/papers/31404502 | PubMed |
| 9 | 26997436 | Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses. | Hum Pathol | 2016 | https://conductscience.org/library/papers/26997436 | PubMed |
| 10 | 20044458 | European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. | Eur Respir J | 2010 | https://conductscience.org/library/papers/20044458 | PubMed |
| 11 | 31030596 | Role of Ryanodine Type 2 Receptors in Elementary Ca2+ Signaling in Arteries and Vascular Adaptive Responses. | J Am Heart Assoc | 2019 | https://conductscience.org/library/papers/31030596 | PubMed |
| 12 | 35308247 | Drug-Related Lymphedema: Mysteries, Mechanisms, and Potential Therapies. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35308247 | PubMed |
| 13 | 19447921 | Reversible airflow obstruction in lymphangioleiomyomatosis. | Chest | 2009 | https://conductscience.org/library/papers/19447921 | PubMed |
| 14 | 27628078 | Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management. | Am J Respir Crit Care Med | 2016 | https://conductscience.org/library/papers/27628078 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 38629073 | TGF-β, IL-1β, IL-6 levels and TGF-β/Smad pathway reactivity regulate the link between allergic diseases, cancer risk, and metabolic dysregulations. | Front Immunol | 2024 | https://conductscience.org/library/papers/38629073 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FKBP1AP2 | 2283 | PubTator's text mining | https://conductscience.org/library/genes/2283 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| RYR2 | 6262 | PubTator's text mining | https://conductscience.org/library/genes/6262 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37589458
GET https://conductscience.org/api/papers/v1/37589458/authors